The Worldwide Market for Respiratory Devices: Forecasts to 2018 (Inhalers, Nebulizers, Airways, Masks, Sleep Apnea, Oxygen Therapy, Ventilators Medical Humidifiers, Respiratory Measurement)

Attention: There is an updated edition available for this report.
 
   Single User - $995
   Site License (one location, 10 users) - $1,495
   Corporate License - $1,990



Loading...
Published Jan 23, 2014 | 150 Pages | Pub ID: KLI5192151

The Worldwide Market for Respiratory Devices (Inhalers, Nebulizers, Airways, Masks, Sleep Apnea, Oxygen Therapy, Ventilators Medical Humidifiers, Respiratory Measurement)

Despite economic downturns mainly owing to the aging of the world population and the increasing incidence of chronic obstructive pulmonary disease (COPD), the worldwide respiratory device industry continues to increase. The business comprises many different offerings to treat and track respiratory conditions as well as many large and small manufacturers. This Kalorama report contains exhaustive business coverage, including estimates and forecasts for the following devices:
  • Inhalers
  • Inhalers, device-only market
  • Nebulizers, Jet
  • Nebulizers, Ultrasonic
  • Airway Masks
  • Cannula
  • Tracheostomy Tubes
  • Sleep Apnea CPAP
  • Sleep Apnea Bi-Level
  • Sleep Apnea Facial Interface
  • Sleep Apnea APAP
  • Oxygen Concentrators
  • Oxygen Systems
  • Ventilators
  • Humidifiers
  • Respiratory Measurement Devices (Oximeters, Capnograph, Others)
  • Resuscitators
For the following global regions, the report includes major industry segment estimates:
  • US
  • Europe
  • Asia
Provided as well are the following country breakdowns:
  • US
  • Germany
  • UK
  • France
  • Japan
  • Brazil
  • Russia
  • India.
The assessment presented in this report is centered on extensive interviews with senior management of top competitors in the worldwide respiratory devices opportunity. From a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals, background data was obtained. Key data from published literature were used to conduct interviews with over 20 industry executives and product managers to validate and obtain expert opinion on current and future trends in the worldwide respiratory devices business. Interviews were also used to confirm and/or adjust industry size estimates, as well as in formulating industry projections.

All industry data pertains to the worldwide opportunity at the manufacturers’ level. Data are expressed in current U.S. dollars. A geographic breakdown is also included for US, Europe, and Asia/Rest of World total business in each segment. The base year for information was 2013. Historical information is provided for each of the years 2011-13, and forecast information are given for each of the years 2014 through 2017. Historical, base year, and forecast information are provided for each industry segment. For the 2013 base year, business shares are given for each industry segment.

Competitors profiled in this report Include:
  • Airsep
  • Astrazeneca
  • Boehringer ingelheim gmbh
  • Covidien
  • Devilbiss Healthcare
  • Fisher & paykel healthcare
  • Ge healthcare
  • Glaxosmithkline
  • Invacare
  • Maquet medical systems
  • Medline
  • Merck & company, inc.
  • Omron healthcare
  • Pari respiratory equipment, inc.
  • Philips/respironics
  • Resmed
  • Smiths Medical
  • Spirometrics
  • Teleflex
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.